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Abstract
Objectives: To explore the cross-sectional association between adiposity, mental well-being, and quality of life in extreme
obese individuals entering a UK specialist weight management service prior to treatment commencement.
Methods: The sample comprised 263 extreme obese individuals who were referred to the service as a result of having a
body mass index (BMI) $40 kg/m2 or $35 kg/m2 with a co-morbid health condition. In a retrospective analysis, routinely
collected baseline clinical examination data and self-report questionnaires (Impact of Weight on Quality of Life: IWQOL-Lite,
EQ5D-3L, and Hospital Anxiety and Depression Scale: HADS) were analysed to examine the cross-sectional association
between adiposity and quality of life.
Results: The sample was predominantly female (74.8%) with mean BMI 47.067.9 kg/m2. Increasing adiposity was
significantly negatively associated with quality of life, with an increase of 1 BMI unit associated with decreases of 1.93 in
physical function (95% CI 22.86 2 21.00, p,0.001), 1.62 in self-esteem (95% CI 22.67 2 20.57, p,0.05), 2.69 in public
distress (95% CI 23.75 2 21.62, p,0.001), 1.33 in work (95% CI 22.63 2 20.02, p,0.05), and 1.79 in total IWQOL-Lite
scores (95% CI 22.65 2 20.93, p,0.001). Adiposity was associated with significantly increased risk of problems in mobility
(OR= 3.44, 95% CI 1.4728.05), and performing usual activities (OR= 2.45, 95% CI 1.1025.46) in highest relative to lowest BMI
tertile. The prevalence of experience of symptoms of anxiety (70.3%) and depression (66.2%) as measured by HADS was
consistently high.
Conclusions: We identified a high prevalence of psychological co-morbidity, including widespread experience of symptoms
of anxiety and depressive disorders and reduced quality of life among these extreme obese individuals seeking weight
management treatment. Clinical implications include the need for the incorporation of strategies to improve mental well-
being into multi-disciplinary weight management interventions.
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Introduction
The prevalence of obesity among adults, and in particular
extreme obesity, has risen rapidly over previous decades [1].
Current levels of extreme obesity (BMI $40 kg/m2) in the US
have increased 70% over the last decade between 2000 and 2010,
with the prevalence rate reaching 6.6% [2], whilst current UK
prevalence rates of extreme obesity are 3% for females and 2% for
males [3]. Indeed, recent estimates predict the rate of extreme
obesity to reach 5% in the UK by 2033 and 9% in the US by 2030
[4]. The physical co-morbidities of extreme obesity are well
documented and research suggests that there are also substantial
negative impacts of adiposity on depression [5], anxiety [6] and
reduced quality of life [7]. However, there are inconsistencies in
the literature, with several reviews reporting studies demonstrating
no association between adiposity and psychological health [5,6,8].
In the extreme obese current understanding is limited as studies
have focused on those individuals specifically seeking bariatric
surgery [9], and have not included a range of assessments of
putative psychological co-morbidities. In order to improve service
provision for patients with extreme obesity, it is important to
understand the extent of psychological co-morbidity and the
impact on quality of life. Baseline data from treatment-seeking
individuals at a community-based UK specialist weight manage-
ment service were analysed as part of the service evaluation to
examine the association between adiposity and psychological
health.
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Materials and Methods
Participants
This cross-sectional service evaluation study included a consec-
utive sample of 262 individuals with extreme obesity entering a
specialist community-based weight management service (CWMS)
in the West Midlands, UK. Eligible participants were referred to
the CWMS by their general practitioner (GP) as a result of
fulfilling the criteria of having a body mass index (BMI) $40 kg/
m2, or alternatively a BMI $35 kg/m2 with a co-morbid health
condition, such as type 2 diabetes mellitus or hypertension. Patient
referral required previous unsuccessful weight loss attempts in
primary care and commercial weight loss programmes. The
participants entered the service between February 2008 and
August 2012, with those included in the evaluation selected from
an opportunity sample. Baseline data including adiposity, quality
of life, and mental well-being were routinely collected prior to the
initiation of treatment.
Demographic information
As part of routine clinical care, demographic and health details
were collected including participants’ age, gender, ethnicity, waist
circumference, smoking status, and alcohol consumption. Details
of participants’ co-morbid health conditions including cardiovas-
cular disease, hypertension, diabetes, obstructive sleep apnoea and
arthritis were also recorded.
Clinical assessment
Within the CWMS, all participants underwent a comprehensive
clinical history and examination by a consultant physician and
specialist dietitian. A psychologist provided further support in the
service. Participants’ initial weight and height data were recorded
at baseline, and BMI was calculated by dividing participants’
weight in kg by height in meters squared.
Quality of life and mental health measures
Questionnaires were routinely collected as part of the compre-
hensive clinical assessment. Quality of life and mental health were
assessed using three measures, the Impact of Weight on Quality of
Life (IWQOL-Lite) questionnaire, which is an obesity-specific
quality of life measure, the EQ5D-3L, which is a general quality of
life measure, and the Hospital Anxiety and Depression Scale
(HADS) which is a screening tool widely used in both clinical and
research settings. The IWQOL-Lite consists of 31 items measuring
the impact of obesity on physical function, self-esteem, sexual life,
public distress and work [10]. Respondents are asked to rate the
extent to which a series of statements is applicable to them using a
Likert scale ranging from 5 ‘Always true’ to 1 ‘Never true’.
Responses to the questionnaire items yield a total impact of weight
on quality of life score as well as individual scores for each of the
five domains, with maximum scores of 100 on each subscale
indicating optimum quality of life.
The EQ5D-3L consists of five questions relating to five
dimensions of health; ‘mobility’, ‘self care’, ‘usual activities’, ‘pain
and discomfort’ and ‘anxiety and depression’ [11]. Respondents
indicate which of a possible three statements best describe their
current health state for each dimension. A ‘level 1’ response
indicates that the respondent has no problem in the specific
dimension, a ‘level 2’ response indicates some problems, and a
‘level 3’ response indicates extreme problems. Respondents are
asked to repeat this process for the five dimensions by indicating
one level for each dimension, giving rise to scores ranging from 1
to 3, with scores of 3 on each dimension indicating the most severe
impairment. Binary variables were computed for each dimension
dichotomising the levels into ‘No problems’ (level 1) and
‘Problems’ (levels 2 and 3). Perceived current health state is
measured by asking respondents to indicate their current health
state on a Visual Analogue Scale (VAS) with endpoints labelled 0
‘Worst imaginable health state’ and 100 ‘Best imaginable health
state’.
The Hospital Anxiety and Depression Scale (HADS) comprises
14 items, 7 relating to anxiety, and 7 relating to depression [12].
Respondents rate the extent to which a series of statements
represents how they currently feel using a Likert scale ranging
from 0 to 3. The scale yields individual anxiety and depression
scores as well as an overall HADS score. Individual subscale for
anxiety and depressive symptom scores range from 0 to 21, with a
score of 8 established as a cut-point for identifying symptoms of
anxiety and depressive disorders and scores of 11 established as a
cut-point for identifying more severe symptoms [13]. Whilst the
HADS scale is widely used in clinical practice to identify the
experience of symptoms of anxiety and depression, it cannot
provide a confirmatory diagnosis of anxiety and depressive
disorders.
Statistical analysis
All data were analysed using SPSS (version 19.0). T-tests, cross-
tabulation, chi2 and analysis of variance (ANOVA) calculations
were conducted to compare the BMI tertile groups: first BMI
tertile #42.99; second BMI tertile 43.00 2 48.61; third BMI
tertile $48.62 kg/m2. Linear regression coefficients were calcu-
lated to assess the relationship between BMI and quality of life as
measured by IWQOL-Lite scores (continuous) and in separate
analyses between BMI and overall perceived health status as
measured by EQ5D-3L VAS. Analyses were conducted for the
whole sample and repeated in gender-stratified sub-groups.
Logistic regression models were constructed to assess the
association between BMI and experience of symptoms of anxiety
and depressive disorder as measured by HADS, and presence of
problems in mobility, self care and performing usual activities as
measured by EQ5D-3L, with the first BMI tertile group as the
reference. The odds ratios (ORs) and 95% confidence intervals
(CIs) for three hierarchical models are presented: crude; adjusting
for age and sex; and additionally adjusting for the co-morbidities;
diabetes, hypertension, arthritis, obstructive sleep apnoea and
cardiovascular disease.
Ethics statement
This was a retrospective analysis of routinely collected data to
evaluate the psychological and quality of life burden of extreme
obesity. Data were anonymised prior to any data analysis. The
anonymised data were analysed as part of the specialist weight
management service evaluation at the Heart of England NHS
Foundation Trust, requiring no specific research ethics approval as
recommended by the UK National Research Ethics Service [14].
The analysis was registered with the local governance audit
department.
Results
Demographic and clinical characteristics
The participants were aged 19 to 76 years, with a mean age of
43.1611.8 years and a mean BMI of 47.067.9 kg/m2. Table 1
shows that in those with increasing levels of adiposity, there were
significantly more problems in mobility, self care and performing
usual activities, and weight was reported to have a greater impact
on physical function, causing public distress, ability to work, and
overall quality of life. Those with increasing BMI were also more
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likely to have type 2 diabetes mellitus, hypertension, obstructive
sleep apnoea (OSA) and cardiovascular disease (CVD). There
were no significant differences in HADS anxiety and depression
scores, with prevalence of anxiety and depressive symptoms
consistently high across the BMI groups, with data for the
combined sample indicating prevalence rates of anxiety symptoms
(70.3%) and depressive symptoms (66.2%), which are far greater
than the UK general population rates of 33.0% for anxiety
disorders and 11.4% for depressive disorders [15]. Indeed, levels of
severe anxiety and depressive symptoms defined by the higher cut-
point scores of $11 are also substantial, with severe anxiety
symptoms experienced by 48.3% of the sample and 40.4% of the
sample experiencing symptoms of severe depressive disorders.
Data indicate that quality of life is impaired, with sample mean
IWQOL-Lite scores ranging from 26.2 (self-esteem) to 51.2 (work),
whereby 100 represents optimum quality of life. Perceived health
status was also poor with a sample mean of 44.0, whereby 100
represents best possible health state; which is considerably worse
than the UK general population mean score of 82.8 [16]. There
were no significant gender differences in EQ5D-3L. However
there were gender differences in HADS anxiety, but not
depression and total scores, and gender differences in the
IWQOL-Lite total and subscales self-esteem and sexual life, with
significantly poorer quality of life in females (data not shown).
Linear regression: BMI, IWQOL-Lite and perceived health
status
The IWQOL-Lite total measure and the subscales physical
function, self-esteem, public distress and work were significantly
negatively associated with increasing BMI (Table 2). Increasing
BMI was associated with decreasing quality of life across the
domains of physical function (1.93, p,0.001), self-esteem (1.62,
p,0.05), public distress (2.69, p,0.001), work (1.33, p,0.05) and
total score (1.79, p,0.001). Stratification by gender revealed that
BMI was more strongly negatively associated with these measures
in males. Interestingly, BMI was not significantly associated with
the sexual life IWQOL-Lite subscale and the perceived health
status measure (EQ5D-3L VAS).
Logistic regression: BMI, EQ5D-3L and HADS anxiety and
depression
Table 3 shows the logistic regression analyses of the EQ5D-3L
subscales ‘mobility’, ‘self care’ and ‘usual activities’, which were
significantly associated with BMI. The fully adjusted model
revealed an increased risk of mobility problems with increased
BMI, with the odds ratios of 1.64 (0.78 2 3.44) and 3.44 (1.47 2
8.05) for second and third BMI tertile groups (P for trend ,0.05)
respectively, compared to those in the first BMI tertile group.
There was a non-significant increased risk of self care problems,
with the odds ratios of 0.89 (0.41 2 1.96) and 1.87 (0.86 2 4.09)
for second and third BMI tertile groups (P for trend = 0.104)
respectively. However the fully adjusted model remained signif-
icant demonstrating increased risk of self care problems in the
continuous BMI model 1.05 (1.00 2 1.09). The fully adjusted
model also revealed an increased risk of problems performing
usual activities, with the odds ratios of 2.04 (0.98 2 4.26) and 2.45
(1.10 2 5.46) for second and third BMI tertile groups (P for trend
,0.05) respectively, compared to those in the first BMI tertile
group. Interestingly, the logistic regression analyses of anxiety and
depressive symptoms as defined as HADS subscale score $8
revealed that anxiety and depressive symptoms were not
significantly associated with BMI across the range encountered
in the sample.
Discussion
The findings of the present evaluation demonstrated that quality
of life was markedly impaired in this sample of extreme obese
individuals entering a specialist community-based weight man-
agement service having not succeeded with previous efforts at
weight loss. Furthermore, we observed that the prevalence of
anxiety and depressive symptoms was very high. Whilst much of
the research investigating the complex association between
adiposity and quality of life and mental well-being has incorpo-
rated individuals across the spectrum of obesity, the present study
is of particular importance as it focuses on the escalating extreme
obese population [4].
We observed a significant negative association between
increasing adiposity at these extreme levels and quality of life,
specifically in the areas of physical function, self-esteem, public
distress and work, with increased adiposity associated with reduced
quality of life as measured by IWQOL-Lite score. The association
between adiposity and weight-specific quality of life as measured
by IWQOL-Lite has been established, with findings indicating that
BMI accounts for approximately 28% of the variance in total
IWQOL-Lite scores [7]. Previous research has shown that scores
vary with degree of adiposity and treatment status, with those with
higher BMI and those seeking treatment reporting significantly
worse quality of life [7]. In addition, changes in IWQOL-Lite
score from baseline to post-intervention have been shown to
correlate significantly with weight loss [17]. The results obtained in
the present study show a similar level of impairment in quality of
life to those obtained in a study of bariatric surgery-seeking
individuals, which reported scores ranging from 40.4 (work) to
46.2 (self-esteem) across IWQOL-Lite subscales [7]. Interestingly,
the present study reported one subscale which was not shown to be
significantly associated with adiposity; sexual life. This is consistent
with findings from a comparison of white and African American
US women, whereby white women scored significantly lower on
sexual life compared to their African American counterparts, in
both class II and III obesity, and BMI was significantly associated
with sexual life in the white sub-group but not in the African
American sub-group [18]. A similar pattern of results whereby
significant association was not observed between BMI and sexual
life has also been reported in a sample of over 400 bariatric
surgery-seeking extreme obese individuals [18]. The investigators
concluded that the lack of observed association is due to the high
level of co-morbidities, which may diminish the association
between quality of life and BMI at the level of extreme obesity.
However, the results of the present study show that the association
between BMI and quality of life remains when controlling for co-
morbid health conditions, suggesting that obesity negatively affects
quality of life, independently of these conditions. This lack of
association indicates that there are additional factors outside of
those measured, which contribute to the reduced level of quality of
life in these specific domains. Indeed, the substantial impairments
in sexual quality of life in this population have been greatly under-
researched [19] and are thought to be associated with the broader
aspects of stigmatisation and discrimination [20] as well as
negative perceived body image [19,21] experienced by this patient
population.
Likewise, significant associations were observed between
adiposity and some, but not all, of the EQ5D-3L subscales.
Adiposity was associated with experience of problems in mobility,
self-care, and performing usual activities, with those in the third
BMI tertile more likely to experience problems in these areas.
Whilst the fully adjusted models remained significant for the
mobility and performing usual activities analyses, the self-care
Adiposity, Mental Well-Being, and Quality of Life
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model was no longer significant when fully adjusted in the BMI
tertile model. These findings are consistent with the limited
previous studies which have shown that general quality of life as
measured by EQ5D-3L is poorest for individuals with class III
obesity, compared to class I and II obese groups, as well as
overweight and underweight groups, relative to those of normal
weight where quality of life scores are optimum [22],[23]. Notably,
the present study reported two subscale scores, which were not
shown to be significantly associated with adiposity, ‘pain and
discomfort’ and ‘anxiety and depression’(data shown in Table 1).
This is in contrast to previous research which has identified that
obese individuals are at greater odds of experiencing anxiety and
depressive disorders [5],[6], and pain (OR=1.94) relative to
normal weight counterparts [23]. The results of the present study
Table 1. Demographic and clinical characteristics of the sample across BMI tertiles.
Whole sample
1st BMI tertile
# 42.99
2nd BMI tertile
43.00 2 48.61
3rd BMI tertile
$ 48.62 P
N 262 87 87 88
Age (years) 43.1611.8 43.0613.2 41.7610.2 44.7611.8 0.234
Sex (% female) 74.8 72.4 77.0 75.0 0.783
Ethnicity (%) 0.585
White European 90.8 90.0 95.5 87.9
Asian 5.6 5.0 2.3 8.6
Black African/Caribbean 2.8 2.5 2.3 3.4
Other 0.7 2.5 0.0 00
Weight (kg) 132.1624.7 112.6614.7 129.1615.6 154.2622.3 ,0.001
Body mass index (BMI, kg/m2) 47.067.9 39.462.6 45.861.6 55.866.6 ,0.001
Waist circumference (cm) 131.6614.5 123.8611.8 128.6612.7 142.4612.5 ,0.001
Systolic blood pressure (mmHg) 140.9617.7 136.0614.5 140.4617.0 146.4620.0 0.009
Diastolic blood pressure (mmHg) 85.2611.7 83.369.7 85.5611.4 86.9613.6 0.263
Diabetes (%) 26.3 24.1 18.4 36.4 0.022
Hypertension (%) 34.4 31.0 26.4 45.5 0.022
Arthritis (%) 24.0 21.8 19.5 30.7 0.190
Obstructive sleep apnoea (OSA, %) 25.6 16.1 26.4 34.1 0.024
Cardiovascular disease (CVD, %) 11.1 9.2 5.7 18.2 0.026
Smoking (%) 25.5 31.7 23.0 22.2 0.655
Alcohol consumption (%) 64.7 62.9 81.0 52.9 0.004
IWQOL-Lite (%) Total 39.5622.1 49.0623.3 38.5619.9 32.1620.2 ,0.001
Physical function 42.4625.3 54.1624.9 40.4623.6 34.1623.7 ,0.001
Self-esteem 26.2627.5 30.4630.5 24.1624.4 24.5627.5 0.286
Sexual life 41.9635.9 47.3636.9 43.5635.6 35.2634.7 0.128
Public distress 40.5628.9 56.6631.5 38.9625.2 27.7622.7 ,0.001
Work 51.2630.3 61.6630.4 46.1627.4 47.1631.3 0.003
EQ5D
Mobility problems % 66.7 55.9 63.0 80.3 0.006
Self care problems % 35.7 29.9 27.2 50.0 0.006
Anxiety/depression problems % 75.3 73.1 75.6 77.0 0.864
Pain/discomfort problems % 85.3 80.0 86.3 89.3 0.272
Usual activities problems % 69.0 58.0 70.4 77.6 0.036
Perceived health status 44.0620.1 47.4619.4 42.4619.0 42.9621.8 0.303
HADS Total score 19.667.7 19.067.6 20.267.8 19.667.9 0.654
HADS anxiety score 10.464.5 10.564.3 10.764.8 10.264.5 0.780
HADS depression score 9.164.0 8.664.0 9.363.9 9.364.1 0.436
Anxiety symptoms $8 (%) 70.3 74.0 68.7 68.8 0.716
Depression symptoms $8 (%) 66.2 62.3 72.5 63.2 0.333
Severe anxiety symptoms $11 (%) 48.3 50.7 48.2 46.3 0.860
Severe depression symptoms $11 (%) 40.4 33.3 42.5 44.7 0.338
Data are percentages and means 6 standard deviations. HADS =Hospital anxiety and depression scale.
doi:10.1371/journal.pone.0092859.t001
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indicate that individuals reported the greatest amount of problems
in these domains. Likewise, no significant association between
adiposity and perceived health status (EQ5D-3L VAS) was
observed. Together, these findings suggest a possible ceiling effect
for the EQ5D-3L tool being unable to detect differences within
such a homogeneous group as the present sample in which the
quality of life is consistently low. An additional aspect is the
absence of normal weight individuals, which truncates the BMI
range, reducing the opportunity to identify an association. There
was a non-significant trend whereby perceived health status was
highest for the first BMI tertile group (47.4) and lowest for the
third BMI tertile group (42.9) supporting the above contentions.
Unlike the present study, previous studies have demonstrated that
perceived health status significantly decreases with increasing
adiposity, and is poorest for individuals with class III obesity,
relative to those of normal weight [23]; it is likely that the expected
significant negative association was not observed in the present
study due to the homogeneity in adiposity of this exclusively
extreme obese sample.
The expected significant associations between adiposity and
symptoms of anxiety and depressive disorder as measured by
HADS were also not observed in the present study. However, it
was evident that the prevalence of symptoms of psychological co-
morbidities was high across the sample (anxiety, 70.3%; depres-
sion, 66.2%) and is far greater than the UK general population
rates of 33.0% for anxiety and 11.4% for depressive disorder [15].
The relationship between depressive disorders and obesity has
been widely documented in the literature, with results from
prospective studies indicating that obesity is associated with future
incidence of depression and cross-sectional studies revealing
significant positive associations between adiposity and depression,
particularly in females [5]. No significant variation in prevalence
of anxiety and depressive symptoms was observed across the levels
of adiposity in the current sample, probably due to the truncated
BMI range and the overall high prevalence of anxiety and
depressive symptoms. However, data from the NHANES
(National Health and Nutrition Examination Survey) study
demonstrated a dose-response relationship between depression
and adiposity, with class III obese individuals having greater odds
of experiencing lifetime major depression (OR=2.60), recurrent
major depression (OR=2.28), depression in the past month
(OR=4.98) and past year (OR=2.92) than the class I and II
obesity groups relative to those of normal BMI [24].
Whilst much research has demonstrated evidence for an
association between adiposity and both depressive and anxiety
disorders [6,24,25] it is important to note that some studies have
reported no significant association [8] or have reported non-
significant trends [26229]. A systematic review and meta-analysis
of the association between obesity and anxiety has concluded that
there is evidence in support of a positive association between
Table 2. Linear regression of BMI predicting IWQOL-Lite subscale and total scores and perceived health status (EQ5D-3L VAS) in
whole sample and stratified by gender.
Univariate Model 1 Model 2
U.B. S.E. S.B U.B. S.E. S.B U.B. S.E. S.B
Physical function 20.83** 0.20 20.26 21.95** 0.48 20.62 21.93** 0.47 20.61
Male { 21.66* 0.54 20.37 21.92* 0.53 20.43 22.00** 0.50 20.44
Female { 20.66* 0.21 20.23 20.56* 0.20 20.19 20.51* 0.21 20.18
Self esteem 20.34 0.22 20.10 21.53* 0.53 20.44 21.62* 0.53 20.47
Male { 21.80* 0.63 20.35 21.39* 0.60 20.27 21.19 0.63 20.23
Female { 0.01 0.22 20.00 20.06 0.22 20.02 20.11 0.22 20.04
Sexual life 20.56 0.32 20.12 21.55* 0.77 20.34 21.45 0.79 20.31
Male { 21.47 0.75 20.25 21.55* 0.76 20.27 21.21 0.81 20.21
Female { 20.33 0.35 20.08 20.27 0.35 20.06 20.29 0.36 20.07
Public distress 21.44** 0.22 20.40 22.82** 0.53 20.77 22.69** 0.54 20.74
Male { 23.00** 0.49 20.62 22.76** 0.48 20.57 22.48** 0.51 20.51
Female { 21.14** 0.24 20.34 21.19** 0.24 20.35 21.18** 0.25 20.35
Work 20.83* 0.25 20.22 21.34* 0.65 20.35 21.33* 0.66 20.35
Male { 21.39* 0.67 20.28 21.23 0.68 20.25 21.22 0.73 20.25
Female { 20.70* 0.27 20.20 20.70* 0.28 20.20 20.68* 0.28 20.19
IWQOL2Lite total 20.79** 0.17 20.28 21.84** 0.43 20.66 21.79** 0.44 20.65
Male { 21.82** 0.44 20.47 21.78** 0.45 20.46 21.60* 0.46 20.42
Female { 20.56* 0.19 20.22 20.54* 0.19 20.22 20.52* 0.19 20.21
Perceived health status 20.17 0.18 20.07 20.12 0.49 20.05 20.07 0.49 20.03
Male { 20.12 0.48 20.04 20.11 0.50 20.03 20.08 0.50 20.03
Female { 20.18 0.19 20.07 20.18 0.20 20.07 20.12 0.20 20.05
U.B. = Unstandardized Beta, S.E. = Standard error, S.B = Standardised Beta.
*P,0.05, **P,0.001.
Model 1 adjusting for age, gender and interaction between BMI and gender.
{Model 1 and 2 adjusting for age only.
Model 2 additionally adjusting for diabetes, hypertension, arthritis, obstructive sleep apnoea, cardiovascular disease.
doi:10.1371/journal.pone.0092859.t002
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obesity and anxiety, with pooled cross-sectional data indicating
that obese individuals are more likely to experience anxiety
(OR=1.4) [6]. It is also of interest that the findings of the present
work indicate that anxiety was more prevalent in this sample than
depression.
The mechanism of the association between adiposity, impair-
ment in quality of life and presence of anxiety and depressive
disorders is not yet established, with several proposed pathways
through which obesity may lead to psychological co-morbidity and
vice versa. Firstly, through the multiple health threats associated
with obesity acting as stressors, and secondly through the negative
effects of stigma and weight-related discrimination. Indeed
frequency of stigmatisation and inability to adopt effective coping
strategies have been shown to result in depressed mood [29]. The
relationship between obesity and depression specifically, appears
to be bi-directional with obesity associated with increased
experience of depressive symptoms, and depressive episodes
associated with further weight gain. Furthermore, obese individ-
uals are more likely to over-eat and gain weight compared to non-
obese individuals during an episode of depression [30]. A
systematic review of the relationship between depression and
adiposity reported that the majority of evidence was cross-sectional
and thus causality could not be established [5].
Previous research has been criticised for the inclusion of only
one measure of quality of life [23], and as such the inclusion of
several quality of life measures is a novel aspect of the present
evaluation. Previous studies have utilised either general measures
such as the EQ5D-3L [22],[23] and the Medical Outcomes Study
Short Form Health Survey (SF-36) [31],[32] or condition specific
measures such as the Obesity Adjustment Survey (OAS) [33] and
the Obesity Related Well-being (ORWELL 97) questionnaire
[34]; however the IWQOL-Lite measure is the most widely used
weight-specific measure [35]. Present findings suggest that in the
assessment of quality of life within extreme obesity, both weight-
specific and general quality of life measures are effective. Notably,
the IWQOL-Lite, EQ5D-3L and HADS measures all contained
subscales which were not associated with adiposity indicating that
each of the tools may have limitations in capability of identifying
differences in extreme adiposity. The specific domains which were
not associated with adiposity; pain and discomfort, anxiety and
depression and sexual life were in fact the more severely affected
aspects of life. Likewise, none of the components of the HADS
mental health screening tool were associated with adiposity.
However, the tool was shown to be effective in determining
prevalence of symptoms of anxiety and depressive disorders in an
extreme obese sample. Future studies should utilise several quality
of life measures, including those that are weight specific and
general in order to establish the validity of the measures in this
patient group [36], as well as enabling deeper understanding of the
additional factors which may influence the complex relationship
between adiposity, quality of life and mental well-being.
A key strength of the present study is that it demonstrates that
the negative impact on quality of life associated with increasing
BMI remains even when controlling for the presence of obesity
Table 3. Logistic regression of presence of problems in mobility, self care and usual activities (EQ5D) and presence of anxiety and
depression (HADS) by BMI tertiles and by continuous BMI.
1st tertile
( # 42.99)
2nd tertile
(43.00 2 48.61) 3rd tertile ( $ 48.62)
P for linear
trend Continuous BMI
Odds ratio (95% CI)
Mobility problems Univariate 1.00 1.25 (0.64 2 2.44) 2.95 (1.40 2 6.22)* 0.004 1.07 (1.02 – 1.12)*
Model 1 1.00 1.32 (0.66 – 2.63) 2.83 (1.31 – 6.15)* 0.008 1.07 (1.02 – 1.12)*
Model 2 1.00 1.64 (0.78 – 3.44) 3.44 (1.47 – 8.05)* 0.009 1.08 (1.03 – 1.13)*
Self care problems Univariate 1.00 0.84 (0.41 – 1.72) 2.19 (1.09 – 4.39)* 0.018 1.05 (1.01 – 1.09)*
Model 1 1.00 0.88 (0.42 – 1.88) 2.05 (0.98 – 4.27) 0.044 1.05 (1.01 – 1.10)*
Model 2 1.00 0.89 (0.41 – 1.96) 1.87 (0.86 – 4.09) 0.104 1.05 (1.00 – 1.09)*
Problems performing
usual activities
Univariate 1.00 1.71 (0.86 – 3.37) 2.65 (1.27 – 5.52)* 0.008 1.05 (1.01 – 1.10)*
Model 1 1.00 1.73 (0.86 – 3.44) 2.48 (1.17 – 5.23)* 0.016 1.05 (1.01 – 1.10)*
Model 2 1.00 2.04 (0.98 – 4.26) 2.45 (1.10 – 5.46)* 0.040 1.05 (1.00 – 1.10)*
Anxiety Univariate 1.00 0.75 (0.37 – 1.51) 0.73 (0.36 – 1.45) 0.409 0.98 (0.95 – 1.02)
Model 1 1.00 0.68 (0.33 – 1.42) 0.74 (0.35 – 1.54) 0.460 0.98 (0.94 – 1.01)
Model 2 1.00 0.71 (0.34 – 1.50) 0.81 (0.37 – 1.74) 0.633 0.98 (0.95 – 1.02)
Depression Univariate 1.00 1.57 (0.78 – 3.15) 1.00 (0.51 – 1.98) 0.958 1.00 (0.96 – 1.03)
Model 1 1.00 1.59 (0.79 – 3.20) 1.06 (0.53 – 2.11) 0.910 1.00 (0.96 – 1.03)
Model 2 1.00 1.65 (0.80 – 3.40) 1.26 (0.61 – 2.62) 0.550 1.00 (0.97 – 1.04)
Presence of problems defined as level 2 (some problems) and level 3 (extreme problems) scores on EQ5D-3L; Presence of anxiety and depression defined as HADS
anxiety subscale score $8.
* P,0.05.
**P,0.001.
Model 1 adjusting for age and sex.
Model 2 additionally adjusting for diabetes, hypertension, arthritis, obstructive sleep apnoea, cardiovascular disease.
doi:10.1371/journal.pone.0092859.t003
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related co-morbid health conditions commonly experienced by the
extreme obese population. Previous studies have concluded that
the association between adiposity and quality of life is mediated by
health co-morbidities such as pain, cardiovascular disease and type
2 diabetes mellitus [37239]; however the present study supports
that the association is independent, and that the role of co-
morbidities in the relationship may have previously been over-
estimated, and the impact of adiposity, underestimated.
An additional strength of the present study is that it improves
understanding of the characteristics of this less-researched extreme
obese population. However, the present work has several
limitations. The individuals characterised in the sample are those
that had sought assistance in managing their weight and as a
consequence it may not be appropriate to extrapolate these
findings to the general extreme obese population, as evidence
suggests that non-treatment-seeking obese individuals do not
experience the same psychological co-morbidities [40] and
impairment in quality of life [7] as those seeking treatment.
Furthermore, the fact that these findings are obtained from a
single weight management service may limit their generalizability
to other UK specialist weight management settings. The cross-
sectional design of the present study means that it is not possible to
confirm a causal relationship between adiposity and quality of life.
The present work also adopted a service evaluation approach
aiming to understand the psychological and quality of life burden
of obesity to improve service provision, which means that it is not
possible to compare the characteristics of the extreme obese
treatment-seeking group, with a non-obese control group or an
extreme obese non-treatment-seeking group for comparison. As
such the findings of the present work should be interpreted with
caution and future studies adopting a controlled design comprising
a control group of extreme obese non-treatment-seeking individ-
uals should be utilised in further investigation of the psychological
co-morbidities of extreme obesity.
In conclusion, we observed that among this sample of
treatment-seeking extreme obese individuals there is a high
prevalence of symptoms of psychological co-morbidity, including
experience of anxiety and depressive disorder symptoms and
reduced quality of life. Increasing adiposity was associated with a
reduction in several areas of quality of life, but was not significantly
associated with symptoms of anxiety and depressive disorders.
These findings are of clinical importance indicating that the
impairment in quality of life and mental health challenges faced by
these individuals must be addressed and incorporated into the
multi-disciplinary care of these patients, in order to provide
tailored weight management interventions.
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